SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has rallied to a fresh 52-week high amid anticipation of its Q3 results, with traders also debating whether the move reflects BRIUMVI growth and momentum or speculative buyout and short-covering activity. The earnings date remains unconfirmed, and the company has not confirmed acquisition rumors.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle is under pressure amid falling lithium spot and futures prices, with traders concerned about the impact on earnings and guidance. The community is split between expecting more downside and viewing the selloff as a buying opportunity, citing longer-term EV and energy-storage demand.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention over weaker 2027 Medicare Advantage star ratings for Aetna, which traders worry could reduce bonus revenue and pressure margins. The reaction is mixed: some see a meaningful setback relative to Humanas improved ratings, while others question whether the impact is already reflected in the stock.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FUBO is drawing attention for a sharp, low-volume slide toward recent lows, with many traders saying the decline lacks a clear news catalyst and voicing concerns about the business, dilution and the post-merger outlook. The discussion is split between bearish calls for further losses and investors waiting for upcoming earnings and the new CEOs strategy update to show whether Disney integration can improve the outlook.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Updated NSCLC trial results and Iovances move toward biomarker-selected patient groups are driving attention: the overall response rate held near prior levels, while a retrospective subgroup showed a stronger signal, but durability and regulatory implications remain uncertain. Traders are split between viewing the subgroup strategy as promising and seeing a narrower, later lung opportunity, with frustration over the datas presentation and the sharp selloff ahead of earnings.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak Q1 results, reduced full-year outlook and dividend suspension are driving attention, with management citing recession-level appliance demand and the Iran war. Traders are sharply divided between fears of further financial distress and hopes that the selloff has created an oversold buying opportunity.

The Clorox Co. engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States. The Household segments consists of bags and wraps, grilling products and cat litter marketed and sold in the United States. The Lifestyle segment refers to food, natural personal care products and water-filtration products marketed and sold in the United States. The International segment covers products sold outside the United States, excluding natural personal care products. The company was founded by Edward Hughes, Charles Husband, William Hussey, Rufus Myers, and Archibald Taft on May 3, 1913 and is headquartered in Oakland, CA.

Clorox Co.

Cloroxs sharply weaker fiscal outlook and ongoing sales and margin pressures have fueled a steep selloff, with traders focused on the earnings-driven decline and fresh lows. The community is split between viewing the lower price and high dividend as a long-term value opportunity and warning that weak execution and a potentially strained payout could mean further downside.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing RRP treatment has put pressure on Precigens PAPZIMEOS, prompting debate over whether the new entrant will erode its sales. Some traders see a threat from the rivals surgery-sparing treatment, while others point to PAPZIMEOS first-mover and commercialization lead and the uncertainty surrounding Inovios accelerated approval and launch.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

CELH is drawing attention for its recent strength as traders discuss money rotating out of tech and look ahead to Q3 earnings. Sentiment is split between hopes for improving sales, Alani Nu growth and stronger recent Nielsen data, and concerns about weakness in the core Celsius brand, margins and management execution.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros steep selloff and repeated 52-week lows are driving discussion, with traders weighing whether the decline is an oversold buying opportunity or a repricing of its still-high valuation amid concerns about consumer spending, growth, and competition. Some point to store expansion and continued business growth as reasons for optimism, while others expect further downside ahead of earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PLAYSTUDIOS Announces 1-for-10 Reverse Stock Split and Provides an Update on Stock Repurchases

PLAYSTUDIOS, Inc. (Nasdaq: MYPS) (the Company) today announced that it will effect a 1-for-10 reverse stock split (the Reverse Stock Split) of its Class A common stock, par value $0.0001 per share (the Class A Common Stock), and Class B common stock, par value $0.0001 per share (the Class B Common...

PLAYSTUDIOS, Inc. Announces Second Quarter Results

PLAYSTUDIOS, Inc. (NASDAQ: MYPS) (PLAYSTUDIOS or the Company), a developer and publisher of free-to-play mobile and social games and the creator of the playAWARDS loyalty platform, today announced financial results for the second quarter ended June 30, 2026. Andrew Pascal, Chairman and Chief...

PLAYSTUDIOS, Inc. (MYPS) Reports Q1 Loss, Beats Revenue Estimates

PLAYSTUDIOS (MYPS) delivered earnings and revenue surprises of -60.00% and +9.59%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PLAYSTUDIOS, Inc. Announces First Quarter Results

PLAYSTUDIOS, Inc. (NASDAQ: MYPS) (PLAYSTUDIOS or the Company), a developer and publisher of free-to-play mobile and social games and the creator of the playAWARDS loyalty platform, today announced...

Century Casinos (CNTY) Reports Q1 Loss, Lags Revenue Estimates

Century Casinos (CNTY) delivered earnings and revenue surprises of +9.38% and -0.41%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PLAYSTUDIOS (MYPS) Projected to Post Earnings on Monday

PLAYSTUDIOS (NASDAQ:MYPS) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-playstudios-inc-stock...

Roblox (RBLX) Reports Q1 Loss, Tops Revenue Estimates

Roblox (RBLX) delivered earnings and revenue surprises of +32.90% and +0.17%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

PLAYSTUDIOS, Inc. (NASDAQ:MYPS) Short Interest Up 35.1% in March

PLAYSTUDIOS, Inc. (NASDAQ:MYPS - Get Free Report) was the recipient of a significant increase in short interest in March. As of March 31st, there was short interest totaling 3,041,144 shares, an increase of 35.1% from the March 15th total of 2,250,285 shares. Currently, 2.8% of the company's stock...

PLAYSTUDIOS (NASDAQ:MYPS) CFO Sells $10,792.80 in Stock

PLAYSTUDIOS, Inc. (NASDAQ:MYPS - Get Free Report) CFO Scott Edward Peterson sold 23,984 shares of the stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of $0.45, for a total value of $10,792.80. Following the completion of the transaction, the chief...

PLAYSTUDIOS (NASDAQ:MYPS) CFO Scott Edward Peterson Sells 23,984 Shares

PLAYSTUDIOS, Inc. (NASDAQ:MYPS - Get Free Report) CFO Scott Edward Peterson sold 23,984 shares of PLAYSTUDIOS stock in a transaction on Tuesday, April 7th. The shares were sold at an average price of...

PLAYSTUDIOS, Inc. engages in developing casual games for mobile and social platforms. It operates through the playGAMES and playAWARDS segments. The playGAMES segment develops and publishes digital games on mobile and web platforms. The playAWARDS segment focuses on loyalty solutions. The company was founded by Paul D. Mathews, Andrew S. Pascal, and Katie Bolich in July 2011 and is headquartered in Las Vegas, NV.

PLAYSTUDIOS Inc - Ordinary Shares - Class A

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.52
Prev Close	$4.60
Open	$4.60
Dividend Yield	0.00%
50-Day Moving Average	$4.61
Beta	0.88
Avg. Volume	34,008.83
PE Ratio	-1.23

52-Week High	$9.20
52-Week Low	$3.53
Market Capitalization	$54.29M
EPS (Annual)	-$2.28
Price to Book	0.27
Revenue Per Employee	$432,959.48

Feed

News

Sentiment

Earnings

Fundamentals

Info

MYPS Fundamentals